{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:02:10Z","timestamp":1790168530364,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03386-8","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:24:25Z","timestamp":1790155465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antecedent, landmark, and two-visit cumulative triglyceride-glucose index and non-traditional lipid measures in relation to incident cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome (CKM) stages 0\u20133: a nationwide prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Aomen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"3386_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"key":"3386_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148:1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"key":"3386_CR3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331:1858\u201360. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"key":"3386_CR4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148:1982\u20132004. https:\/\/doi.org\/10.1161\/CIR.0000000000001191.","journal-title":"Circulation"},{"key":"3386_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43:61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"key":"3386_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21:68. https:\/\/doi.org\/10.1186\/s12933-022-01511-x.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR7","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4:e23\u201333. https:\/\/doi.org\/10.1016\/S2666-7568(22)00247-1.","journal-title":"Lancet Healthy Longev"},{"key":"3386_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21:124. https:\/\/doi.org\/10.1186\/s12933-022-01546-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","volume":"20","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20:76. https:\/\/doi.org\/10.1186\/s12933-021-01268-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK Biobank data. Cardiovasc Diabetol. 2023;22:34. https:\/\/doi.org\/10.1186\/s12933-023-01762-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, Jin J, Wang F, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:22. https:\/\/doi.org\/10.1186\/s12933-025-02589-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-025-02732-6","volume":"24","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li W, Zhou H, et al. Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0\u20133: insights from CHARLS. Cardiovasc Diabetol. 2025;24:168. https:\/\/doi.org\/10.1186\/s12933-025-02732-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12933-024-02350-8","volume":"23","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang L, Wang L, et al. The predictive value of cumulative atherogenic index of plasma for cardiovascular outcomes: a prospective community-based cohort study. Cardiovasc Diabetol. 2024;23:264. https:\/\/doi.org\/10.1186\/s12933-024-02350-8.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-023-02044-7","volume":"22","author":"H Zheng","year":"2023","unstructured":"Zheng H, Wu K, Wu W, et al. Relationship between cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study. Cardiovasc Diabetol. 2023;22:313. https:\/\/doi.org\/10.1186\/s12933-023-02044-7.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-025-02754-0","volume":"24","author":"L Lu","year":"2025","unstructured":"Lu L, Chen Y, Liu B, et al. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:202. https:\/\/doi.org\/10.1186\/s12933-025-02754-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03307-9","author":"Y Geng","year":"2026","unstructured":"Geng Y, Peng Z, Tang S, Lin Q. Associations of the triglyceride-glucose index, lipid-derived parameters, and their joint exposure with incident cardiometabolic multimorbidity: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03307-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.numecd.2023.01.003","volume":"33","author":"Y Liu","year":"2023","unstructured":"Liu Y, Jin X, Fu K, et al. Non-traditional lipid profiles and the risk of stroke: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2023;33:698\u2013714. https:\/\/doi.org\/10.1016\/j.numecd.2023.01.003.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3386_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"key":"3386_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23:292. https:\/\/doi.org\/10.1186\/s12933-024-02352-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:296. https:\/\/doi.org\/10.1186\/s12933-025-02848-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515\u201326. https:\/\/doi.org\/10.1093\/biomet\/81.3.515.","journal-title":"Biometrika"},{"key":"3386_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144.","journal-title":"J Am Stat Assoc"},{"key":"3386_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133:601\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017719.","journal-title":"Circulation"},{"key":"3386_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"FE Harrell Jr","year":"2015","unstructured":"Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. Cham: Springer; 2015. https:\/\/doi.org\/10.1007\/978-3-319-19425-7.","edition":"2"},{"key":"3386_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377\u201399. https:\/\/doi.org\/10.1002\/sim.4067.","journal-title":"Stat Med"},{"key":"3386_CR26","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32:5381\u201397. https:\/\/doi.org\/10.1002\/sim.5958.","journal-title":"Stat Med"},{"key":"3386_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB, Sr, Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u201372. https:\/\/doi.org\/10.1002\/sim.2929.","journal-title":"Stat Med"},{"key":"3386_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24:277. https:\/\/doi.org\/10.1186\/s12933-025-02842-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-025-02593-z","volume":"24","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liang Y, Li J, Li X, Yu M, Cui W. Correlation between atherogenic index of plasma and cardiovascular disease risk across cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:40. https:\/\/doi.org\/10.1186\/s12933-025-02593-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24:254. https:\/\/doi.org\/10.1186\/s12933-025-02784-8.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","volume":"22","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang X, Wang Y, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22:2. https:\/\/doi.org\/10.1186\/s12933-022-01732-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR32","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1097\/JS9.0000000000001795","volume":"110","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Shen J, Chen P, et al. Association of triglyceride glucose index with stroke: from two large cohort studies and Mendelian randomization analysis. Int J Surg. 2024;110:5409\u201316. https:\/\/doi.org\/10.1097\/JS9.0000000000001795.","journal-title":"Int J Surg"},{"key":"3386_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-022-01541-5","volume":"21","author":"H Li","year":"2022","unstructured":"Li H, Zuo Y, Qian F, et al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21:105. https:\/\/doi.org\/10.1186\/s12933-022-01541-5.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12933-023-02076-z","volume":"22","author":"H Zhou","year":"2023","unstructured":"Zhou H, Ding X, Lan Y, Chen S, Wu S, Wu D. Multi-trajectories of triglyceride-glucose index and lifestyle with cardiovascular disease: a cohort study. Cardiovasc Diabetol. 2023;22:341. https:\/\/doi.org\/10.1186\/s12933-023-02076-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12933-025-02972-6","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang C, He S, Xie G, et al. Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China. Cardiovasc Diabetol. 2025;24:431. https:\/\/doi.org\/10.1186\/s12933-025-02972-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12933-025-02582-2","volume":"24","author":"R Assempoor","year":"2025","unstructured":"Assempoor R, Daneshvar MS, Taghvaei A, et al. Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies. Cardiovasc Diabetol. 2025;24:35. https:\/\/doi.org\/10.1186\/s12933-025-02582-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3386_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.5551\/jat.63118","volume":"29","author":"H Hu","year":"2022","unstructured":"Hu H, Fukunaga A, Yokoya T, et al. Non-high-density lipoprotein cholesterol and risk of cardiovascular disease: the Japan Epidemiology Collaboration on Occupational Health Study. J Atheroscler Thromb. 2022;29:1295\u2013306. https:\/\/doi.org\/10.5551\/jat.63118.","journal-title":"J Atheroscler Thromb"},{"key":"3386_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011;8:222\u201332. https:\/\/doi.org\/10.1038\/nrcardio.2010.222.","journal-title":"Nat Rev Cardiol"},{"key":"3386_CR39","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","volume":"119","author":"MA Hlatky","year":"2009","unstructured":"Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408\u201316. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192278.","journal-title":"Circulation"},{"key":"3386_CR40","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000001453","volume":"154","author":"CE Ndumele","year":"2026","unstructured":"Ndumele CE, Rodriguez F, Dixon DL, et al. 2026 AHA\/ACC\/ADA\/ASN guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;154:e50\u2013158. https:\/\/doi.org\/10.1161\/CIR.0000000000001453.","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03386-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03386-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03386-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:13:04Z","timestamp":1790165584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03386-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3386"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03386-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"11 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CHARLS was approved by the Biomedical Ethics Review Board of Peking University (IRB00001052-11015 for the household survey and IRB00001052-11014 for blood collection). All participants provided written informed consent. The present secondary analysis used de-identified public data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"285"}}